Stay updated on Dupilumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page
- Check2 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the previously visible study record details for NCT03749135. This indicates the study information is temporarily inaccessible due to an access restriction or site issue.SummaryDifference18%

- Check44 days agoChange DetectedAdded a funding note for 2017 (NIH grant/contract) in the study identifiers and updated the page revision from v3.6.5 to v3.6.6, reflecting new funding information and the current document version.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page shows Revision: v3.6.5 replacing Revision: v3.6.4, indicating a small site revision. The update does not alter the study information or how users interact with the page.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous revision number. This indicates an updated version of the page, likely due to minor editorial or QC updates.SummaryDifference0.1%

- Check102 days agoChange DetectedThe page revision tag has been updated to v3.6.3, indicating a newer build of the ClinicalTrials.gov entry. This generally reflects maintenance or bug fixes and does not alter trial data or study details.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.